Week of December 13, 2021 |
|
COVID on My Mind
COVID is not yet done with us. Our daughter-in-law Kelly, who has received her booster, developed cold symptoms, lost her taste of smell and tested positive this past week. So, now all the members of our sons’ families have contracted COVID-19 — nine people. Fortunately, Kelly is not terribly symptomatic. Ken and his family are fully recovered, back at work and school, and so decamped to the beach for the weekend. We decided to stay home out of an abundance of irrational caution. When our little granddaughter Isabelle heard we would not be joining them, she broke down and cried. However, when we FaceTimed them on Saturday, she told us not to come because “we have the coronavirus.” She is 3 1/2 years old, and this is her reality.
|
|
Booster Shots Available on Campus This Week
Georgetown is providing additional opportunities for students, faculty and staff to receive a COVID-19 vaccine booster shot on the Main Campus and at the Law Center, beginning today, Monday, December 13. View dates and times and register in advance.
|
|
GUMC Community Meeting:
“Celebrating Achievements”
Wednesday, December 15
4:00 - 5:00 p.m.
Pre-Clinical Science Building LA-6 or via Zoom
Reception to follow. Masks are required and distancing encouraged. In support of the DC community, please consider bringing new or gently used winter outerwear (coats, hats, gloves, scarves and socks) to support the GUPD’s Winter Coat Drive benefiting Catholic Charities. RSVP to attend.
|
|
Potter Award Recipients Announced |
|
Jinani Jayasekera, PhD, and Chul Kim, MD, MPH, were announced this week as the 2021 recipients of the John F. Potter, MD Award. Established in 2017 in honor of Georgetown Lombardi’s founder, John F. Potter, MD, the award recognizes the achievements of a rising star researcher. Read the full announcement.
|
|
|
|
Research Reveals How Aging Cells Can Be an Underlying Cause of Kidney Damage
A study in mice by researchers at Georgetown Lombardi has found that stress and tissue damage initiated by angiotensin II, a molecule that is known to increase blood pressure and stiffening in the linings of blood vessels, leads to cellular senescence, a process by which a cell ages and permanently stops dividing but does not die. Importantly, when the researchers eliminated senescent cells from the mice, tissues returned to a normal state in spite of a continued infusion of angiotensin II. Read more about this research.
|
|
Smith Named a National Academy of Inventors Fellow
Jill P. Smith, MD, professor of medicine and Georgetown Lombardi METRO Program member, has been named a fellow of the National Academy of Inventors (NAI). The NAI Fellows Program highlights academic inventors who have demonstrated a spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development and the welfare of society. View a complete list of the NAI Fellows Program Class of 2021.
|
|
Announcing the Establishment of a GUMC Ombudsperson
A new role at GUMC, the faculty ombudsperson provides an informal, impartial, independent and confidential environment where faculty can discuss workplace concerns and disputes, and seek solutions. Additionally, the ombudsperson acts as a source of information and referral, and assists in the informal resolution of concerns and critical solutions. Bassem R. Haddad, MD, professor of oncology and obstetrics and gynecology, will serve a three-year term as the inaugural faculty ombudsperson starting January 1. Read the announcement.
|
|
NCI Launches Early Investigator Advancement Program
The National Cancer Institute is launching the Early Investigator Advancement Program (EIAP) to facilitate the advancement of scientists from diverse backgrounds to become independent investigators. Each year, EIAP will support the professional and career development of a cohort of eligible and qualified early stage investigators and new investigators from institutions across the country.
The program will:
- Enhance professional skills;
- Guide preparation of an R01 grant application;
- Offer access to a mentoring and peer network; and
- Provide a professional and career development webinar series
|
|
Tuesday, December 14
12:00 - 1:00 p.m.
Ozlem Dilek, PhD, assistant professor of chemistry in the Division of Sciences and Mathematics in the College of Arts and Sciences at the University of the District of Columbia, presents “Bright and Rapid Click-Chemistry Strategies: ‘Turn-Off/On’ Probes for Live Cell Imaging.” Sponsored by the Department of Biochemistry and Molecular & Cellular Biology. Join the Bhussry Seminar via Zoom.
|
|
Tuesday, December 14
6:00 - 7:00 p.m.
In recognition of World AIDS Day, this virtual session in the series promoting clinical research awareness, diversity in research, and community engaged research through virtual outreach efforts features the presentation “Understanding HIV Pre-exposure and Preventative Measures in Cis-Gender Women & the Importance of Clinical Trial Randomization” by Rachel K. Scott, MD, MPH, assistant professor of obstetrics and gynecology at Georgetown. Sponsored by GHUCCTS. Register for this session via Zoom.
|
|
Thursday, December 16
4:00 - 5:00 p.m.
Michelle Digman, PhD, associate professor, co-equity advisor for the Henry Samueli School of Engineering, BME Associate Chair for Graduate Affairs, Department of Biomedical Engineering, University of California, Irvine, presents “Metabolic Imaging Using the Phasor Approach to FLIM and Tracking Phenotypic Change of Mitochondria in Cancer Cells with Mitometer.” Note: CME/CE credit may be offered for this seminar. Join the Dean’s Seminar via Zoom.
|
|
Friday, December 17
12:00 - 1:00 p.m.
|
|
Tuesday, December 21
4:00 - 5:00 p.m.
Via Zoom
Learn how to upload your CV, add your personal website information, upload a syllabus, publications and more. Register for this class.
|
|
Funding and Award Opportunities
Basser External Research Grant Program
The Basser External Research Grant Program, administered by the The Basser Center for BRCA at Penn Medicine’s Abramson Cancer Center, focuses on projects that have the potential to advance the care of individuals living with BRCA1 and BRCA2 mutations. Research grant applications in basic science, prevention, early detection, or targeted therapeutics and relevant to the study of BRCA1/2 will be considered. Submission by early stage investigators is encouraged. Three high-risk idea projects will be awarded (one-year projects, up to $100,000). Six-month progress updates and final reports are required. View full details plus application forms. Submit a mandatory LOI via the Research Grants Administration portal by Monday, Dec. 20.
_______________________________
Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program
The Bristol Myers Squibb Foundation Diversity in Clinical Trials Career Development Program (BMSF DCTCDP) is a two-year program designed to support the career development of early-stage investigator (as defined by NIH) physicians underrepresented in medicine, or physicians who have a demonstrated commitment to increasing diversity in clinical research, to become independent clinical trial investigators who are engaged in advancing health equity through their research and mentoring. Awardees receive $120K/year for two years; requires at least 40% of the scholar’s time. View more information. LOI deadline: January 14, 2022. Application opens (by invitation only): January 31, 2022.
_______________________________
Mary Kay Ash Foundation 2022 Cancer Research Grants
The Mary Kay Ash Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research for cancers affecting women, including but not limited to ovarian, uterine, breast and/or cervical cancer. Principal Investigator must be appointed a full-time assistant professor or higher at the time of application submission and commit a minimum 5% effort. Grants will be awarded in the amount of $100,000 over a two-year period. View more information. Please submit grant documentation to Sharon Levy (sgl5@georgetown.edu) by Jan. 21, 2022.
_______________________________
NEW Damon Runyon Clinical Investigator Award
The Damon Runyon Clinical Investigator Award supports the most promising early career physician-scientists willing to devote their efforts to the development and application of new diagnostic approaches and therapeutic strategies for cancer and cancer prevention through clinical investigation. Preference is given to those whose research adheres to the “Handshake Rule,” meaning that the physician will conduct research studies that directly involve patients. The award will provide $600,000 over three years in financial support for the investigator’s scientific needs. In addition, the foundation will retire up to $100,000 of medical school debt owed by the awardee. Five nominations will be accepted for review from Georgetown Lombardi. Finalists will be invited to be interviewed by the selection committee. Only one application will be accepted from a mentor (including co-mentorships) or investigator per review session. View detailed award information, eligibility criteria, application guidelines and forms. Application deadline: Feb. 1, 2022.
|
|
Meetings in italics should be attended by all fellows.
|
|
9:00 AM | Breast Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 528212194)
11:00 AM | GU/Melanoma Research Meeting | Podium A / Zoom (dial 646-558-8656; Meeting ID: 796253566)
12:15 PM | ASH Meeting/No Conference. Encouraged to look through ASH abstracts. | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | GU Tumor Board (on 1st/3rd Mondays of the month) | Podium A / Zoom (dial 646-558-8656; Meeting ID: 869742463)
|
|
9:00 AM | Hematology Path Conference - Inpatient Heme fellows + Outpatient Heme + BMT fellow | Podium A / Microsoft Teams (CME code: 87757)
12:15 PM | ASH Meeting/No Conference. Encouraged to look through ASH abstracts. | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
4:00 PM | Liver Tumor Board | WebEx (dial 844-302-0362; Meeting number (access code): 711 507 430, password: Mse4mGSA2N5)
5:00 PM | Breast Tumor Board | Podium A / Zoom (dial 646-558-8656; Meeting ID: 93777073374; CME code: 80044)
|
|
8:00 AM | Thoracic Tumor Board – Thoracic Fellow | Podium A / Zoom
9:00 AM | Thoracic Research Meeting – Thoracic Fellow | Podium A / Microsoft Teams
12:15 PM | WHC Lecture – Dr. Juan Beaoncloche (NCI) – Neutropenic Fever | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
|
|
9:30 AM | Head and Neck Tumor Board - Thoracic Fellow attendance encouraged as clinic allows | Microsoft Teams
12:15 PM | Dr. Dunleavy – BTK Inhibitor Update | Podium A / Zoom (dial 646-558-8656; Meeting ID: 987 3224 3543)
12:30 PM | GI Research Meeting | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
7:00 AM | CNS Tumor Board | Zoom (dial 646-558-8656; Meeting ID: 378 807 316)
12:00 PM | Oncology Grand Rounds Lecture Series: Kornelia Polyak, MD, PhD | “Breast Tumor Evolution” | Zoom
1:00 PM | Pancreas Tumor Boar d | WebEx (dial 844-302-0362, Meeting Number (access code): 712527865, HOST PIN: 5514)
|
|
Connect with Georgetown Lombardi on Social Media |
|
If you would like to share news or updates from your department, please get in touch with Sarah Riehl. |
|
|
|
|
|
|
